Rocket Lab has delivered over 550% returns since my November 2024 'Buy' rating initiation. Click here to read an analysis of RKLB stock now.

Jan. 16, 2026 A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts ...